Two cases of extensively drug-resistant (XDR) Neisseria gonorrhoeae infection combining ceftriaxone-resistance and high-level azithromycin resistance, France, November 2022 and May 2023.

Authors :: Maubaret C
Caméléna F
Mrimèche M
Braille A
Liberge M
Mainardis M
Guillaume C
Noel F
Bébéar C
Molina JM
Lot F
Chazelle E
Berçot B
Source :: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2023 Sep; Vol. 28 (37).
Publication Year :: 2023
Abstract: We report two extensively drug-resistant (XDR) Neisseria gonorrhoeae (NG) isolates combining high-level resistance to azithromycin and resistance to ceftriaxone, obtained in France from two heterosexual patients, one of whom returned from Cambodia. Whole genome sequencing identified MLST ST16406, the mosaic penA -60.001 which caused ceftriaxone resistance in the internationally spreading FC428 clone, and the A2059G mutation in the 23S rRNA gene. The NG isolates F93 and F94 were related to XDR isolates detected in Austria and the United Kingdom in 2022.

Subjects :: Humans
Azithromycin pharmacology
France
Multilocus Sequence Typing
Neisseria gonorrhoeae genetics
Ceftriaxone pharmacology
Gonorrhea diagnosis
Gonorrhea drug therapy

Language :: English
ISSN :: 1560-7917
Volume :: 28
Issue :: 37
Database :: MEDLINE
Journal :: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Publication Type :: Academic Journal
Accession number :: 37707979
Full Text :: https://doi.org/10.2807/1560-7917.ES.2023.28.37.2300456

Full Text Access

Tools